Efficacy of Remimazolam with Fentanyl versus Midazolam with Fentanyl
Phase 1
- Conditions
- Screening patientsTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- CTIS2023-503470-21-00
- Lead Sponsor
- Herlev Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Age over 18, Scheduled for elective colonoscopy screening for colon cancer, Must be able to provide informed written consent.
Exclusion Criteria
Requiring general anesthesia., Allergy to Midazolam, Remimazolam, opioids or ingredients.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method